SecBot SecBot

WGS

GeneDx Holdings Corp.
Nasdaq· Services-Health Services· Inc. DE· CIK 0001818331 Healthcare & Medical Devices
$51.02 −1.35 (−2.58%)
Nov 16 4:00 PM ET · prev $52.37
Market cap
$1.6B
Small cap
Consensus
Buy
92% Buy or better · 12 analysts
Median target
$84.00
+65% · range $65.00–102.00
1 year
−60.6%
from $129.55 · Nov 17
30 days
−23.0%
from $66.29
52-week range
$34.51–167.51
−70% from high · low May 5
Avg volume 20D
1.14M
Nov 10 spike 3.36M
Short interest
6.55M
≈22.0% of shares · +8.8%
Days to cover
7.3
at average volume
Insider net
+$22.1M
1 buyer · 2 sellers · since May 19
New fund stakes
1
Q2 2026 13F · 5 exits
Filing reports
13
analyzed by SecBot
SecBot read BULLISH 6 reports · 90 days
Balance 1 bearish · 1 bullish · 4 neutral oldest → newest, height = score
Avg score ·High conf. 5/6

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $25.1M at an average $47.85. 2 insiders sold $3.0M. Price is 7% above their cost.

  • InstitutionsMIXED

    Q2 2026: 30 added (1 new), 26 trimmed or exited. Largest new: Jane Street Group $14.0M.

  • AnalystsBULLISH

    11 of 12 rate it Buy or better. Every target is above the price.

  • Short sellersSTEADY

    Short interest +8.8% to 6.55M shares. 7.3 days to cover, ≈22.0% of shares.

  • TrendDOWNTREND

    30% below its 50-day average.

  • SocialQUIET

    No Reddit mentions this week. Last mention Nov 7.

Who's buying

13F· Q2 2026
1
new positions
5
exits
$14.0M
in new stakes
FundMoveSharesValue
Corvex Management LPADD4,784,570$328.5M
GOLDMAN SACHS GROUP INCADD1,669,441$114.6M
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLCADD1,400,653$96.2M
MORGAN STANLEYADD988,297$67.8M
CITADEL ADVISORS LLCADD865,462$59.4M
Aberdeen Group plcADD457,201$31.4M
BANK OF AMERICA CORP /DE/ADD346,211$23.8M
Assenagon Asset Management S.A.DOUBLED303,433$20.8M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

12 analysts
Buy 92% rate it Buy or better
Strong Buy4Buy7Hold1Sell0Strong Sell0
12-month targets · 8 analysts

Price is below the lowest target. Median implies +65%.Targets as of Nov 16, 2026.

Recent actions
DateFirmActionRating
Nov 10, 2026BTIG
MAINTAIN
MAINTAINBuy
Oct 1, 2026Guggenheim
MAINTAIN
MAINTAINBuy
Aug 4, 2026Canaccord Genuity
MAINTAIN
MAINTAINBuy
Aug 4, 2026BTIG
REITERATE
REITERATEBuy
Jun 29, 2026Guggenheim
MAINTAIN
MAINTAINBuy
Jun 23, 2026Piper Sandler
MAINTAIN
MAINTAINOverweight

Insider ledger

Form 4
$25.1M
bought · 1 insider
$3.0M
sold · 2 insiders
+6.6%
vs their $47.85 cost
DateInsiderTypeValue
Sep 17, 2026
Fuchs Thomas
Director
Sep 17, 2026
EXERCISE1,146 sh
Sep 16, 2026
Feeley Kevin
CHIEF FINANCIAL OFFICER
Sep 16, 2026
SELL$106.8K
Sep 16, 2026
Feeley Kevin
CHIEF FINANCIAL OFFICER
Sep 16, 2026
SELL$55.2K
Sep 16, 2026
Feeley Kevin
CHIEF FINANCIAL OFFICER
Sep 16, 2026
SELL$5.0K
Sep 16, 2026
Feeley Kevin
CHIEF FINANCIAL OFFICER
Sep 16, 2026
EXERCISE7,197 sh
Sep 16, 2026
Feeley Kevin
CHIEF FINANCIAL OFFICER
Sep 16, 2026
SELL$144.5K
Sep 16, 2026
Feeley Kevin
CHIEF FINANCIAL OFFICER
Sep 16, 2026
SELL$52.4K
Sep 16, 2026
Stueland Katherine
CHIEF EXECUTIVE OFFICER
Sep 16, 2026
EXERCISE18,750 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 30, 2026
6,552,860
shares short
+8.8%
vs prior settlement
7.3
days to cover
≈22.0%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 13, 2026 SEC
ARK Investment Management LLC and Catherine D. Wood filed Amendment No. 2 to Schedule 13G, disclosing a 6.42% passive…
SC 13G/A · Impact 3/10
Nov 9, 2026 SEC
GeneDx reported Q3 2026 revenue of $123.1M (+5% YoY) and adjusted EPS of $0.28, beating the $0.07 consensus. Exome and…
8-K · Impact 6/10
Nov 9, 2026 Earnings result
WGS Q3 2026 Earnings: EPS $0.28 (+280.4% vs est)
Nov 6, 2026 SEC
William Blair Investment Management disclosed a 5.2% passive stake in GeneDx Holdings Corp. via a new Schedule 13G…
SC 13G · Impact 3/10
Sep 17, 2026 Insider
Fuchs Thomas acquired via exercise 1,146 shares
Director
Sep 16, 2026 Insider
Feeley Kevin sold 1,079 shares
CHIEF FINANCIAL OFFICER @ $99.00 ($106.8K)
Sep 16, 2026 Insider
Feeley Kevin sold 586 shares
CHIEF FINANCIAL OFFICER @ $94.26 ($55.2K)
Jun 30, 2026 Inst.
Corvex Management LP · ADD
4,784,570 shares ($328.5M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Nov 9, 2026
Earnings result
WGS Q3 2026 Earnings: EPS $0.28 (+280.4% vs est)
Oct 26, 2026
Earnings date
WGS Q3 2026 Earnings Scheduled, 2026-10-26
Aug 3, 2026
Press release
DEADLINE TODAY: GeneDx Holdings Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - WGS
LOS ANGELES, Aug. 3, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against GeneDx Holdings Corp. ("GeneDx" or…
Aug 3, 2026
Press release
DEADLINE TODAY: GeneDx Holdings Corp. Investor Alert: Contact SBS by August 3, 2026 for Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, Aug. 3, 2026 /PRNewswire/ -- Schall Brown & Schwartz LLP, a national shareholder rights litigation firm, reminds investors of a class…
Aug 3, 2026
Earnings date
WGS Q2 2026 Earnings Scheduled, 2026-08-03

SecBot reports

13 filings · 4 bullish · 3 bearish · 6 neutral
All WGS filing & press-release reports (13)